Report Detail

Pharma & Healthcare Global Gastrointestinal Therapeutics and Diagnostics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2772937
  • |
  • 17 January, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.

Scope of the Report:
This report focuses on the Gastrointestinal Therapeutics and Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Gastrointestinal Therapeutics and Diagnostics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Abbott Laboratories
Allergan
AstraZeneca
Bayer AG
GlaxoSmithKline
Janssen Pharmaceuticals
Takeda Pharmaceutical
Valeant Pharmaceuticals
Pfizer
AbbVie, Inc.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Diagnostics
Therapeutics

Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

There are 15 Chapters to deeply display the global Gastrointestinal Therapeutics and Diagnostics market.
Chapter 1, to describe Gastrointestinal Therapeutics and Diagnostics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Gastrointestinal Therapeutics and Diagnostics, with sales, revenue, and price of Gastrointestinal Therapeutics and Diagnostics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Gastrointestinal Therapeutics and Diagnostics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Gastrointestinal Therapeutics and Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Gastrointestinal Therapeutics and Diagnostics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

    1 Market Overview

    • 1.1 Gastrointestinal Therapeutics and Diagnostics Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Diagnostics
      • 1.2.2 Therapeutics
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital Pharmacies
      • 1.3.2 Retail Pharmacies
      • 1.3.3 Online Pharmacies
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2013-2023)
        • 1.4.1.2 Canada Market States and Outlook (2013-2023)
        • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2013-2023)
        • 1.4.2.2 France Market States and Outlook (2013-2023)
        • 1.4.2.3 UK Market States and Outlook (2013-2023)
        • 1.4.2.4 Russia Market States and Outlook (2013-2023)
        • 1.4.2.5 Italy Market States and Outlook (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2013-2023)
        • 1.4.3.2 Japan Market States and Outlook (2013-2023)
        • 1.4.3.3 Korea Market States and Outlook (2013-2023)
        • 1.4.3.4 India Market States and Outlook (2013-2023)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
        • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
        • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
        • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Abbott Laboratories
      • 2.1.1 Business Overview
      • 2.1.2 Gastrointestinal Therapeutics and Diagnostics Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2 Allergan
      • 2.2.1 Business Overview
      • 2.2.2 Gastrointestinal Therapeutics and Diagnostics Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Allergan Gastrointestinal Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3 AstraZeneca
      • 2.3.1 Business Overview
      • 2.3.2 Gastrointestinal Therapeutics and Diagnostics Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4 Bayer AG
      • 2.4.1 Business Overview
      • 2.4.2 Gastrointestinal Therapeutics and Diagnostics Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Bayer AG Gastrointestinal Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5 GlaxoSmithKline
      • 2.5.1 Business Overview
      • 2.5.2 Gastrointestinal Therapeutics and Diagnostics Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 GlaxoSmithKline Gastrointestinal Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6 Janssen Pharmaceuticals
      • 2.6.1 Business Overview
      • 2.6.2 Gastrointestinal Therapeutics and Diagnostics Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Janssen Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7 Takeda Pharmaceutical
      • 2.7.1 Business Overview
      • 2.7.2 Gastrointestinal Therapeutics and Diagnostics Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Takeda Pharmaceutical Gastrointestinal Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8 Valeant Pharmaceuticals
      • 2.8.1 Business Overview
      • 2.8.2 Gastrointestinal Therapeutics and Diagnostics Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Valeant Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9 Pfizer
      • 2.9.1 Business Overview
      • 2.9.2 Gastrointestinal Therapeutics and Diagnostics Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Pfizer Gastrointestinal Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.10 AbbVie, Inc.
      • 2.10.1 Business Overview
      • 2.10.2 Gastrointestinal Therapeutics and Diagnostics Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 AbbVie, Inc. Gastrointestinal Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    3 Global Gastrointestinal Therapeutics and Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Gastrointestinal Therapeutics and Diagnostics Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Gastrointestinal Therapeutics and Diagnostics Manufacturer Market Share in 2017
      • 3.3.2 Top 6 Gastrointestinal Therapeutics and Diagnostics Manufacturer Market Share in 2017
    • 3.4 Market Competition Trend

    4 Global Gastrointestinal Therapeutics and Diagnostics Market Analysis by Regions

    • 4.1 Global Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Gastrointestinal Therapeutics and Diagnostics Sales and Market Share by Regions (2013-2018)
      • 4.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue and Market Share by Regions (2013-2018)
    • 4.2 North America Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 4.3 Europe Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 4.5 South America Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)

    5 North America Gastrointestinal Therapeutics and Diagnostics by Countries

    • 5.1 North America Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Gastrointestinal Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
      • 5.1.2 North America Gastrointestinal Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
    • 5.2 United States Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 5.3 Canada Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 5.4 Mexico Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)

    6 Europe Gastrointestinal Therapeutics and Diagnostics by Countries

    • 6.1 Europe Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Gastrointestinal Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
      • 6.1.2 Europe Gastrointestinal Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
    • 6.2 Germany Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 6.3 UK Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 6.4 France Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 6.5 Russia Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 6.6 Italy Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)

    7 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics by Countries

    • 7.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
      • 7.1.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
    • 7.2 China Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 7.3 Japan Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 7.4 Korea Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 7.5 India Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 7.6 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)

    8 South America Gastrointestinal Therapeutics and Diagnostics by Countries

    • 8.1 South America Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Gastrointestinal Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
      • 8.1.2 South America Gastrointestinal Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
    • 8.2 Brazil Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 8.3 Argentina Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 8.4 Colombia Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)

    9 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics by Countries

    • 9.1 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
      • 9.1.2 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
    • 9.2 Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 9.3 UAE Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 9.4 Egypt Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 9.5 Nigeria Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
    • 9.6 South Africa Gastrointestinal Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)

    10 Global Gastrointestinal Therapeutics and Diagnostics Market Segment by Type

    • 10.1 Global Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Market Share by Type (2013-2018)
      • 10.1.1 Global Gastrointestinal Therapeutics and Diagnostics Sales and Market Share by Type (2013-2018)
      • 10.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue and Market Share by Type (2013-2018)
    • 10.2 Diagnostics Sales Growth and Price
      • 10.2.1 Global Diagnostics Sales Growth (2013-2018)
      • 10.2.2 Global Diagnostics Price (2013-2018)
    • 10.3 Therapeutics Sales Growth and Price
      • 10.3.1 Global Therapeutics Sales Growth (2013-2018)
      • 10.3.2 Global Therapeutics Price (2013-2018)

    11 Global Gastrointestinal Therapeutics and Diagnostics Market Segment by Application

    • 11.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Application (2013-2018)
    • 11.2 Hospital Pharmacies Sales Growth (2013-2018)
    • 11.3 Retail Pharmacies Sales Growth (2013-2018)
    • 11.4 Online Pharmacies Sales Growth (2013-2018)

    12 Gastrointestinal Therapeutics and Diagnostics Market Forecast (2018-2023)

    • 12.1 Global Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Gastrointestinal Therapeutics and Diagnostics Market Forecast by Regions (2018-2023)
      • 12.2.1 North America Gastrointestinal Therapeutics and Diagnostics Market Forecast (2018-2023)
      • 12.2.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Forecast (2018-2023)
      • 12.2.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Forecast (2018-2023)
      • 12.2.4 South America Gastrointestinal Therapeutics and Diagnostics Market Forecast (2018-2023)
      • 12.2.5 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Forecast (2018-2023)
    • 12.3 Gastrointestinal Therapeutics and Diagnostics Market Forecast by Type (2018-2023)
      • 12.3.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Forecast by Type (2018-2023)
      • 12.3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Type (2018-2023)
    • 12.4 Gastrointestinal Therapeutics and Diagnostics Market Forecast by Application (2018-2023)
      • 12.4.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Forecast by Application (2018-2023)
      • 12.4.2 Global Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Application (2018-2023)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Gastrointestinal Therapeutics and Diagnostics . Industry analysis & Market Report on Gastrointestinal Therapeutics and Diagnostics is a syndicated market report, published as Global Gastrointestinal Therapeutics and Diagnostics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Gastrointestinal Therapeutics and Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,773.56
      4,160.34
      5,547.12
      3,225.96
      4,838.94
      6,451.92
      542,984.40
      814,476.60
      1,085,968.80
      290,649.60
      435,974.40
      581,299.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report